LTR Pharma Logo

LTR Pharma

LTR Pharma is a Clinical Stage Biopharmaceutical Company

SPONTAN® (SDS-089) is a novel intranasal drug (PDE5) delivery platform for Erectile Dysfunction

About Erectile Dysfunction

Erectile Dysfunction (ED) is a condition in which you are unable to get or keep an erection firm enough for satisfactory sexual intercourse. ED can be a short-term or long-term problem.

Our Solution

SPONTAN® provides on demand delivery and faster effect. A lower dose provides less systematic exposure and reduced side effects

Commercialisation

LTR Pharma is commercialising a ‘First in Class’ rapid treatment for Erectile Dysfunction (ED) SPONTAN® with fast-track US NDA Filing within two years

322M

worldwide expected cases by 2025

10

minute effectiveness

$7.10B

projected global market value 2024

Global Market Need

ED is a serious and common medical problem with significant impacts to both physical and psychological health
ED has been identified as a major factor in relationship breakdown (20%). The worldwide prevalence doubled in the last 30 years and is expected to increase to 322 million in 2025.

ON DEMAND
SOLUTION

LTR Pharma Couple

RAPID ONSET
ACTION

BRING BACK
SPONTANEITY

SPONTAN® Now Available at TerryWhite Chemmart Pharmacies Nationwide

LTR Pharma is pleased to announce that SPONTAN® is now available through TerryWhite Chemmart’s network of 600+ pharmacies nationwide, marking a pivotal milestone in our patient access strategy. Under our partnership with Symbion, patients with prescriptions from healthcare professionals can now have them filled at participating TerryWhite Chemmart, Pharmacy Choice,

Read More »

LTR Pharma Signs Collaborative Development Agreement to Develop a Novel Intranasal Spray for Oesophageal Motility Disorders

LTR Pharma has announced that it has entered into a collaborative development agreement with Strategic Drug Solutions, Inc. (SDS) to co-develop OROFLOW®, a novel intranasal spray for Oesophageal Motility Disorders (OMD). OROFLOW® represents an important expansion of the Company’s nasal spray technology platform, designed to provide rapid symptom relief for

Read More »

Conversation Series | Patient Perspectives | Meet Steve Jones

In our latest Conversation Series video, we meet Steve Jones – a prostate cancer survivor whose candid story highlights the profound psychological impact of erectile dysfunction after surgery.  Meet Steve Jones – prostate cancer survivor and sexual health advocate   When Steve Jones was diagnosed with prostate cancer four years ago,

Read More »

Special Access Scheme

SPONTAN may be prescribed to eligible patients under the TGA’s Special Access Scheme. For more information, please register your details via our online form.

Receive our latest news and investor updates

By entering your email address you are agreeing to our privacy policy.